Adverse events were reported in 128 (79%) of the 162 patients within the safety group. The events reported in more than 5% of the patients were drowsiness, decreased appetite, diarrhea, fatigue, seizures, appetite changes, status epilepticus, lethargy, changes in the concentrations of concomitant antiepileptic drugs, gait disorders and sedation. The majority of adverse events were mild or moderate and transient.
Sunday, February 10, 2019
within the safety group
The maximum dose at the 12 week visit was 41 mg / kg / day. Five (3%) patients were titrated at 50 mg / kg / day during the 12 weeks, but their dose was reduced before the week 12 consultation CBD Gummies. The mean dose of cannabidiol at 12 weeks was 22.9 mg / kg (SD 9.1) in the safety analysis group and 22.7 mg / kg (8.5) in the efficacy analysis group.
Adverse events were reported in 128 (79%) of the 162 patients within the safety group. The events reported in more than 5% of the patients were drowsiness, decreased appetite, diarrhea, fatigue, seizures, appetite changes, status epilepticus, lethargy, changes in the concentrations of concomitant antiepileptic drugs, gait disorders and sedation. The majority of adverse events were mild or moderate and transient.
Adverse events were reported in 128 (79%) of the 162 patients within the safety group. The events reported in more than 5% of the patients were drowsiness, decreased appetite, diarrhea, fatigue, seizures, appetite changes, status epilepticus, lethargy, changes in the concentrations of concomitant antiepileptic drugs, gait disorders and sedation. The majority of adverse events were mild or moderate and transient.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment